Sanofi, Actelion Seek to Iron Out Differences in Deal Talks

French drug company Sanofi ’s attempts to acquire Swiss biotech firm Actelion could hit the same roadblock as a similar attempt by J&J, now abandoned: price.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news